Correlation Between Akanda Corp and Evoke Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akanda Corp and Evoke Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akanda Corp and Evoke Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akanda Corp and Evoke Pharma, you can compare the effects of market volatilities on Akanda Corp and Evoke Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akanda Corp with a short position of Evoke Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akanda Corp and Evoke Pharma.

Diversification Opportunities for Akanda Corp and Evoke Pharma

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Akanda and Evoke is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Akanda Corp and Evoke Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evoke Pharma and Akanda Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akanda Corp are associated (or correlated) with Evoke Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evoke Pharma has no effect on the direction of Akanda Corp i.e., Akanda Corp and Evoke Pharma go up and down completely randomly.

Pair Corralation between Akanda Corp and Evoke Pharma

Given the investment horizon of 90 days Akanda Corp is expected to generate 0.79 times more return on investment than Evoke Pharma. However, Akanda Corp is 1.26 times less risky than Evoke Pharma. It trades about 0.02 of its potential returns per unit of risk. Evoke Pharma is currently generating about -0.01 per unit of risk. If you would invest  168.00  in Akanda Corp on October 25, 2024 and sell it today you would lose (3.00) from holding Akanda Corp or give up 1.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Akanda Corp  vs.  Evoke Pharma

 Performance 
       Timeline  
Akanda Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Akanda Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Akanda Corp may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Evoke Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evoke Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Evoke Pharma is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Akanda Corp and Evoke Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akanda Corp and Evoke Pharma

The main advantage of trading using opposite Akanda Corp and Evoke Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akanda Corp position performs unexpectedly, Evoke Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evoke Pharma will offset losses from the drop in Evoke Pharma's long position.
The idea behind Akanda Corp and Evoke Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Transaction History
View history of all your transactions and understand their impact on performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume